China · Delayed Price · Currency is CNY Wuhan Easy Diagnosis Biomedicine Company Description
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally.
Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products.
The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services.
It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection.
The company was founded in 2008 and is based in Wuhan, China.
| Country | China |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 812 |
| CEO | Chen Li Li |
Contact Details
Address: East Lake New Technology Development Zone Wuhan China | |
| Phone | 86 27 6552 3649 |
Stock Details
| Ticker Symbol | 002932 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000033Q7 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Chen Li Li | Chairman and GM |
| Wang Ying | Vice Chairman and Deputy GM |
| Rui Wang | Deputy GM, Chief Financial Officer and Board Secretary |
| Chaohui Li | Accounting Supervisor |